Jaguar Health, Inc. (NASDAQ:JAGX) | WebDisclosure

Basculer en Français

11319	Companies
251539	Keywords
180664	Articles
137355	Press releases

Home
Companies
Jaguar Health, Inc.

PRESS RELEASE

published on 06/18/2026 at 15:00, 4 months 23 days ago

Magdalena Biosciences, a Joint Venture Between Jaguar Health and Filament Health, Announces Positive Results of Preclinical Study of Coca for Weight Gain Prevention
Magdalena's drug candidate, a coca leaf extract, shows promise for post-GLP-1 weight loss management. Preclinical study results suggest potential as weight maintenance therapy

Preclinical Study Magdalena GLP-1 Therapy Weight Loss Management Coca Leaf Extract
BRIEF

published on 06/12/2026 at 15:05, 4 months 29 days ago

Jaguar Health to Present at Life Sciences Virtual Investor Forum

Crofelemer Jaguar Health Intestinal Failure Life Sciences Forum Pediatric Studies
BRIEF

published on 06/12/2026 at 15:05, 4 months 29 days ago

Jaguar Health présentera ses services lors du Forum virtuel des investisseurs en sciences de la vie

Crofelemer Jaguar Health Insuffisance Intestinale Forum Des Sciences De La Vie Études Pédiatriques
PRESS RELEASE

published on 06/12/2026 at 15:00, 4 months 29 days ago

Jaguar Health Presenting June 24, 2026 at the Life Sciences Virtual Investor Forum to Provide Updates on Company's Crofelemer Development Program for Rare Intestinal Failure Diseases
Jaguar Health, Inc. announces virtual presentation by CEO Lisa Conte at Life Sciences Virtual Investor Forum on June 24, 2026. Crofelemer presentations at ESPGHAN Meeting

Virtual Presentation Jaguar Health Lisa Conte Life Sciences Forum ESPGHAN Meeting
BRIEF

published on 06/08/2026 at 22:20, 5 months 2 days ago

Jaguar Health Stockholders Approve All Proposals at 2026 Meeting

Jaguar Health Lisa Conte Emerging Growth Conference Annual Meeting Stockholder Proposals
BRIEF

published on 06/08/2026 at 22:20, 5 months 2 days ago

Les actionnaires de Jaguar Health approuvent toutes les propositions lors de l'assemblée générale de 2026.

Jaguar Health Lisa Conte Réunion Annuelle Conférence Sur La Croissance Émergente Propositions Des Actionnaires
PRESS RELEASE

published on 06/08/2026 at 22:15, 5 months 2 days ago

Jaguar Health Reports Approval of All Proposals at 2026 Annual Meeting of Stockholders
Jaguar Health, Inc. announces approval of proposals at the Annual Meeting of Stockholders. Founder Lisa Conte to present virtually on June 10, 2026 at the Emerging Growth Conference

Virtual Presentation Jaguar Health Lisa Conte Emerging Growth Conference Annual Meeting
BRIEF

published on 05/28/2026 at 16:05, 5 months 14 days ago

Jaguar Health's Ethnobotanical Research Advances Crofelemer Development

Crofelemer Microvillus Inclusion Disease Intestinal Failure Ethnobotanical Medicine Sustainable Harvesting
BRIEF

published on 05/28/2026 at 16:05, 5 months 14 days ago

Les recherches ethnobotaniques de Jaguar Health font progresser le développement du crofelemer

Crofelemer Insuffisance Intestinale Maladie À Inclusions Microvillositaires Médecine Ethnobotanique Récolte Durable
PRESS RELEASE

published on 05/28/2026 at 16:00, 5 months 14 days ago

Jaguar Health Research in Ethnobotanical Medicine Helps Advance Crofelemer Development for Genetically Defined Rare Congenital Gastrointestinal Disorders
Jaguar Health's crofelemer, an FDA-approved botanical drug derived from Croton lechleri tree, developed as first oral adjunctive therapy for Intestinal Failure (IF) from MVID and SBS, highlighting unique botanical drug platform and indigenous collaboration

Crofelemer Jaguar Health FDA-approved Botanical Drug Intestinal Failure

Accesswire

Published on 11/11/2026 at 16:30, 58 minutes ago

ShelfieTech Announces Expansion Agreement for Its Next-Generation AI Retail Intelligence Platform
Published on 11/11/2026 at 14:25, 3 hours 3 minutes ago

Route1 Announces 2026 Annual Meeting Results
Published on 11/11/2026 at 14:00, 3 hours 28 minutes ago

PPX Mining Reports Callanquitas Operating Results for the First Nine Months of 2026
Published on 11/11/2026 at 14:00, 3 hours 28 minutes ago

NuRAN Wireless Board Approves Growth Strategy to Scale Recurring Revenue from 5,000+ Contracted Towers
Published on 11/11/2026 at 13:15, 4 hours 13 minutes ago

Amarc Extends 2026 Exploration Program at the Duke District: Initiates Drilling Program at Established Porphyry Copper-Gold Targets

View all ACCESSWIRE

EQS Group

Published on 11/11/2026 at 17:05, 22 minutes ago

Issue of Equity
Published on 11/11/2026 at 17:05, 22 minutes ago

EQS-Adhoc: Mutares signs agreement to sell Guascor Energy to Oaktree for an Equity Value of EUR 74.0 million
Published on 11/11/2026 at 16:51, 36 minutes ago

Research Dynamics - Report on CPHN: Investor Day Update
Published on 11/11/2026 at 16:50, 38 minutes ago

Gerhard Hanke appointed CEO of Wienerberger AG
Published on 11/11/2026 at 16:45, 42 minutes ago

EQS-Adhoc: Ad-hoc: Gerhard Hanke appointed CEO of Wienerberger AG

Les Echos

Published on 11/10/2026 at 18:00, 23 hours 28 minutes ago

Déclaration du nombre total des droits de vote et du nombre d’actions au 31 octobre 2026
Published on 11/10/2026 at 17:45, 23 hours 43 minutes ago

Damartex / Descriptif du programme de rachat d'actions
Published on 11/10/2026 at 17:40, 23 hours 48 minutes ago

Production du 3ième trimestre 2026
Published on 11/10/2026 at 17:35, 23 hours 53 minutes ago

ENGIE - Déclaration du nombre total d'actions et de droits de vote au 31 octobre 2026
Published on 11/10/2026 at 17:31, 23 hours 56 minutes ago

CNP Assurances SA annonce le succès de l’émission d’une obligation subordonnée Tier 2 de 500 M€.

View all LES ECHOS COMFI WIRE